Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Nakatanti
Clinical Experience of Late Conversion From Antimetabolites With Standard Exposure Calcineurin Inhibitors to Everolimus With Calcineurin Inhibitor Minimization in Stable Kidney Transplant Recipients With Good Renal Function
Transplantation Proceedings
Surgery
Transplantation
Related publications
Safety and Immunologic Benefits of Conversion to Sirolimus in Kidney Transplant Recipients With Long-Term Exposure to Calcineurin Inhibitors
Korean Journal of Internal Medicine
Internal Medicine
Comparison of Calcineurin Inhibitors With M-Tor Inhibitors in Renal Transplant Patients
Akdeniz Medical Journal
Conversion From Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplantation: A Single Centre Experience
Turkish Nephrology, Dialysis and Transplantation Journal
Surgery
Urology
532 Switching From Calcineurin Inhibitors to Belatacept Decreases Keratinocyte Carcinomas Incidence Rate in Kidney Transplant Recipients
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
The Influence of Calcineurin Inhibitors on Pulse Wave Velocity in Renal Transplant Recipients
Renal Failure
Medicine
Nephrology
Critical Care
Intensive Care Medicine
ELEVATE: An Innovative Study Design to Assess the Efficacy, Safety, and Evolution of Cardiovascular Parameters in De Novo Kidney Transplant Recipients After Early Conversion From a Calcineurin Inhibitor to Everolimus
Open Access Journal of Clinical Trials
Toxicology
Pharmaceutics
Pharmacology
Efficacy of a Reduced Pill Burden on Therapeutic Adherence to Calcineurin Inhibitors in Renal Transplant Recipients: An Observational Study
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Experience With Antithymocyte Globulin (Atg) in Pediatric Renal Transplant Recipients
Pediatric Research
Child Health
Pediatrics
Perinatology
Renal Recovery After Conversion to an Everolimus-Based Immunosuppression in Early and Late Heart Transplant Recipients: A 12-Month Analysis
Experimental and Clinical Transplantation
Transplantation
